November 28, 2022
Transcript: Our mission at LungLife is driven from important and compelling statistical data about lung cancer. We have some exciting news to share. Our company is using artificial intelligence to aid with the early detection of lung cancer. LungLife has developed technology that pairs a simple blood draw with artificial intelligence to provide clinicians and […]
• Read MoreNovember 28, 2022
Transcript: Our mission at LungLife is driven from important and compelling statistical data about lung cancer. More than 1.5 million indeterminate lung nodules are found every year in the United States just from CT scans alone, and that number will likely rise as additional screening is performed because COVID has been found to produce indeterminate […]
• Read MoreNovember 28, 2022
Transcript: Our mission at LungLife is driven from important and compelling statistical data about lung cancer. According to the American Society of Clinical Oncology, Lung cancer is the leading cancer killer in the world. At LungLife, we’re creating a different future. While lung cancer isn’t totally preventable, early detection is key to a positive prognosis. […]
• Read MoreNovember 28, 2022
Transcript: Our mission at LungLife is driven from important and compelling statistical data about lung cancer. According to the American Society of Clinical Oncology, more than 2.2 million new people were diagnosed with lung cancer in 2020. That’s one new lung cancer diagnosis every 14 seconds worldwide. Every 14 seconds, someone’s life is turned upside […]
• Read MoreNovember 28, 2022
Transcript: Our mission at LungLife is driven from important and compelling statistical data about lung cancer. According to the American Society of Clinical Oncology, Lung cancer is the leading cancer killer in the world. In 2020 alone, almost 1.8 million people died worldwide from lung cancer. To put this number in perspective, 1.8 million people […]
• Read MoreJuly 6, 2022
Transcript: Hello. My name is Benjamin Katchman, Director of Research and Development at LungLife AI. Today I am going to discuss LungLife’s diagnostic test, LungLB® and the impact that we believe LungLB® will have on improving the early detection of Lung Cancer while simultaneously helping to reduce unnecessary biopsies. At LungLife we have created a […]
• Read MoreJune 6, 2022
Transcript: This is Dan Schoettlin, Director of Quality Assurance with LungLife AI, and today I want to talk about, "Why do we implement quality systems?" When asked, many people say we implement quality systems because various regulations require them. Starting with this reasoning is a major driving factor that results in quality systems that are […]
• Read MoreMay 18, 2022
Transcript: Hello, my name is David Anderson, CFO at LungLife. The ability to detect lung cancer early is crucial in being able to cure this pernicious cancer. Currently, early detection is possible if either you're eligible under a lung cancer screening program using a low dose CT scan as described by the US Preventative Services […]
• Read MoreApril 13, 2022
Transcript: Hello, my name is David Anderson, CFO at Lung Life. At LungLife, our purpose is to be a driving force in the early detection of lung cancer. There are two big myths about lung cancer. Firstly, that if detected, the odds of long term survival are low, and secondly, it's a cancer that only […]
• Read MoreApril 6, 2022
Transcript: Hello, my name is David Anderson, CFO at LungLife. Advocacy is a crucial component in tackling lung cancer. Foundations can often reach further, and in unique directions, compared to physicians and researchers to provide value to all constituents and stakeholders by making sure everyone's concerns are heard. We were recently introduced to the White […]
• Read More
LungLife AI licensure/accreditation information posted here.